Platelet-derived growth factor receptor
Immunolocalization of platelet‐derived growth factor receptor‐β (PDGFR‐β) and pericytes in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL)
14
Tyrphostin AG1296, a platelet-derived growth factor receptor inhibitor, induces apoptosis, and reduces viability and migration of PLX4032-resistant melanoma cells
9
Olaratumab: a platelet-derived growth factor receptor-α-blocking antibody for the treatment of soft tissue sarcoma
6
Inhibition of the platelet-derived growth factor receptor beta (PDGFRB) using gene silencing, crenolanib besylate, or imatinib mesylate hampers the malignant phenotype of mesothelioma cell lines
15
Inhibition of the platelet derived growth factor receptor beta (PDGFRB) using gene silencing, crenolanib besylate, or imatinib mesylate hampers the malignant phenotype of mesothelioma cell lines
17
Function and regulation of Platelet-Derived Growth Factor Receptor Alpha during development
224
Structural analysis of platelet-derived growth factor receptor alpha by protein homology modeling
25
CP-673451, a platelet-derived growth-factor receptor inhibitor, suppresses lung cancer cell proliferation and migration
7
Medical approach to the treatment of feline injection site sarcoma with masitinib: a case report
5
B cell depletion therapy in patients with diffuse systemic sclerosis associates with a significant decrease in PDGFR expression and activation in spindle like cells in the skin
9
Inhibition of Bone Marrow-Derived Mesenchymal Stem Cells Homing Towards Triple-Negative Breast Cancer Microenvironment Using an Anti-PDGFRβ Aptamer
13
Genetic alteration and mutation profiling of circulating cell-free tumor DNA (cfDNA) for diagnosis and targeted therapy of gastrointestinal stromal tumors
8
Case Report Myxoid epithelioid gastrointestinal stromal tumor harboring an unreported PDGFRA mutation: report of a case and review of the literature
9
Original Article The overexpression of PDGF-BB and its receptor is correlated with lymphatic metastasis in patients with non-small cell lung cancer
8
PDGF/PDGFR effects in osteosarcoma and the “add-on” strategy
9
Molecular mechanisms underlying therapeutic potential of pericytes
12
Effect of tyrosine kinase inhibitors, imatinib and nilotinib, in murine lipopolysaccharide induced acute lung injury during neutropenia recovery
11
Reducing lung function decline in patients with idiopathic pulmonary fibrosis: potential of nintedanib
8
Regional expression of the platelet derived growth factor and its receptors in a primate graft model of vessel wall assembly
12
The Bovine Papillomavirus E5 Protein Requires a Juxtamembrane Negative Charge for Activation of the Platelet-Derived Growth Factor β Receptor and Transformation of C127 Cells
9